Central Pharmaceutical Joint Stock Company No. 3 reports 12% profit growth

Central Pharmaceutical Joint Stock Company No. 3 reported a 12.43% increase in after-tax profit for the first six months of 2025, reaching VND 55.96 billion, up from VND 49.77 billion in the same period last year.

The growth came despite total revenue declining by VND 17.3 billion, as the company cut total costs by VND 23.5 billion through a 33% reduction in advertising fees and 38% decrease in salary expenses.